Shahbazi Hamed 4
4 · Niagen Bioscience, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Shahbazi Hamed
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2025-06-24+20,000→ 20,000 totalExercise: $14.13From: 2026-06-24Exp: 2035-06-23→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Option vests 100% on June 24, 2026.
Signature
/s/ Jeong James Lee, Attorney-in-Fact|2025-07-02